SCHEMBL23309584

SCHEMBL23309584

CCOc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.57
▸ RAB9A P51151 8/20 0.57
▸ KMT2A Q03164 6/20 0.57
▸ MEN1 O00255 5/20 0.57
▸ MAPT P10636 3/20 0.57
▸ MAPK1 P28482 2/20 0.57
▸ POLB P06746 2/20 0.57
▸ APOBEC3A P31941 1/20 0.57
▸ APOBEC3G Q9HC16 1/20 0.57
▸ AHR P35869 1/20 0.55
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ TP53 P04637 3/20 0.54
▸ HTT P42858 2/20 0.54
▸ LMNA P02545 2/20 0.54
▸ TAS1R3 Q7RTX0 1/20 0.54
▸ TAS1R1 Q7RTX1 1/20 0.54
▸ GAA P10253 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.52
▸ ALOX15 P16050 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309511 0.87 KMT2A (0.52) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309617 0.86 NPC1 (0.54) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309730 0.85 KMT2A (0.47) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309645 0.84 ALDH1A1 (0.51) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309516 0.83 MEN1 (0.57) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309528 0.82 PRSS12 (0.44) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309621 0.81 RAB9A (0.50) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309562 0.81 PNLIP (0.56) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309707 0.81 ABL1 (0.54) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL23309490 0.78 GAA (0.51) NPC1RAB9AKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL NPC1 412/4885RAB9A 286/4885KMT2A 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback